FT Options’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
$442K Buy
+8,825
New +$442K 0.67% 32
2017
Q2
Sell
-22,834
Closed -$806K 75
2017
Q1
$806K Sell
22,834
-6,359
-22% -$224K 1.06% 22
2016
Q4
$365K Buy
+29,193
New +$365K 0.42% 43
2016
Q3
Sell
-80,799
Closed -$798K 123
2016
Q2
$798K Buy
80,799
+49,503
+158% +$489K 0.69% 24
2016
Q1
$529K Buy
31,296
+21,296
+213% +$360K 0.55% 29
2015
Q4
$223K Buy
+10,000
New +$223K 0.16% 65